Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED)

v3.23.3
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
Total
Adoption of ASU 2016-13
After Adoption of ASU 2016-13
Common Stock
Common Stock
After Adoption of ASU 2016-13
Additional Paid-In Capital
Additional Paid-In Capital
After Adoption of ASU 2016-13
Accumulated Deficit
Accumulated Deficit
Adoption of ASU 2016-13
Accumulated Deficit
After Adoption of ASU 2016-13
Beginning Balance at Dec. 31, 2021 $ 103,908     $ 11,384   $ 105,511   $ (12,987)    
Beginning Balance (in shares) at Dec. 31, 2021       15,622            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net (loss) income (5,027)             (5,027)    
Vesting of restricted stock (59)     $ (6)   (53)        
Vesting of restricted stock (in shares)       153            
Stock-based compensation expense 571     $ 57   514        
Ending Balance at Mar. 31, 2022 99,393     $ 11,435   105,972   (18,014)    
Ending Balance (in shares) at Mar. 31, 2022       15,775            
Beginning Balance at Dec. 31, 2021 103,908     $ 11,384   105,511   (12,987)    
Beginning Balance (in shares) at Dec. 31, 2021       15,622            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net (loss) income (3,901)                  
Ending Balance at Sep. 30, 2022 101,350     $ 11,518   106,720   (16,888)    
Ending Balance (in shares) at Sep. 30, 2022       15,923            
Beginning Balance at Mar. 31, 2022 99,393     $ 11,435   105,972   (18,014)    
Beginning Balance (in shares) at Mar. 31, 2022       15,775            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net (loss) income 528             528    
Vesting of restricted stock (62)     $ (6)   (56)        
Vesting of restricted stock (in shares)       148            
Stock-based compensation expense 489     $ 49   440        
Ending Balance at Jun. 30, 2022 100,348     $ 11,478   106,356   (17,486)    
Ending Balance (in shares) at Jun. 30, 2022       15,923            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net (loss) income 598             598    
Stock-based compensation expense 404     $ 40   364        
Ending Balance at Sep. 30, 2022 101,350     $ 11,518   106,720   (16,888)    
Ending Balance (in shares) at Sep. 30, 2022       15,923            
Beginning Balance at Dec. 31, 2022 $ 102,624 $ (632) $ 101,992 $ 11,591 $ 11,591 107,372 $ 107,372 (16,339) $ (632) $ (16,971)
Beginning Balance (in shares) at Dec. 31, 2022 15,973     15,973 15,973          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net (loss) income $ 641             641    
Vesting of restricted stock (181)     $ (18)   (163)        
Vesting of restricted stock (in shares)       82            
Stock-based compensation expense 509     $ 51   458        
Ending Balance at Mar. 31, 2023 102,961     $ 11,624   107,667   (16,330)    
Ending Balance (in shares) at Mar. 31, 2023       16,055            
Beginning Balance at Dec. 31, 2022 $ 102,624 $ (632) $ 101,992 $ 11,591 $ 11,591 107,372 $ 107,372 (16,339) $ (632) $ (16,971)
Beginning Balance (in shares) at Dec. 31, 2022 15,973     15,973 15,973          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net (loss) income $ (31,492)                  
Ending Balance at Sep. 30, 2023 $ 71,484     $ 11,690   108,257   (48,463)    
Ending Balance (in shares) at Sep. 30, 2023 16,287     16,287            
Beginning Balance at Mar. 31, 2023 $ 102,961     $ 11,624   107,667   (16,330)    
Beginning Balance (in shares) at Mar. 31, 2023       16,055            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net (loss) income 1,102             1,102    
Vesting of restricted stock (301)     $ (30)   (271)        
Vesting of restricted stock (in shares)       232            
Stock-based compensation expense 444     $ 44   400        
Ending Balance at Jun. 30, 2023 104,206     $ 11,638   107,796   (15,228)    
Ending Balance (in shares) at Jun. 30, 2023       16,287            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net (loss) income (33,235)             (33,235)    
Stock-based compensation expense 513     $ 52   461        
Ending Balance at Sep. 30, 2023 $ 71,484     $ 11,690   $ 108,257   $ (48,463)    
Ending Balance (in shares) at Sep. 30, 2023 16,287     16,287